Active, Not Recruiting
A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer
NCT05346224
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- the First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
- The Second Hospital of Anhui Medical University Hefei, Anhui, China
- The first affiliated hospital of Anhui Medical University Hefei, Anhui, China
- The first affiliated hospital of USTC (Anhui Provincial Hospital) Hefei, Anhui, China